Logo image of NAVA.OL

NAVAMEDIC (NAVA.OL) Stock Price, Quote, News and Overview

OSL:NAVA - Euronext Oslo - NO0010205966 - Common Stock - Currency: NOK

26.3  +0.3 (+1.15%)

NAVA.OL Quote, Performance and Key Statistics

NAVAMEDIC

OSL:NAVA (7/22/2025, 3:28:16 PM)

26.3

+0.3 (+1.15%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High33.5
52 Week Low17.1
Market Cap464.46M
Shares17.66M
Float9.04M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PE10.44
Earnings (Next)N/A N/A
IPO03-31 2006-03-31


NAVA.OL short term performance overview.The bars show the price performance of NAVA.OL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 5 10 15 20

NAVA.OL long term performance overview.The bars show the price performance of NAVA.OL in the last 1, 2 and 3 years. 1 year 2 years 3 years -5 -10 -15 -20 -25

The current stock price of NAVA.OL is 26.3 NOK. In the past month the price increased by 20.93%. In the past year, price decreased by -21.69%.

NAVAMEDIC / NAVA Daily stock chart

NAVA.OL Competitors/Peers

The largest stocks on the EU markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
1LLY.MI ELI LILLY & CO 57.38 641.15B
LLY.DE ELI LILLY & CO 55.9 624.66B
ZEG.DE ASTRAZENECA PLC 15.96 366.78B
JNJ.DE JOHNSON & JOHNSON 16.66 343.59B
1JNJ.MI JOHNSON & JOHNSON 16.41 338.39B
NOV.DE NOVO NORDISK A/S-B 18.03 252.38B
RHO.DE ROCHE HOLDING AG-BR 14.38 234.52B
1SAN.MI SANOFI 10.82 202.60B
SAN.PA SANOFI 10.73 201.01B
SNW.DE SANOFI 10.7 200.41B
1NOVN.MI NOVARTIS AG-REG 14.06 197.51B
NOT.DE NOVARTIS AG-REG 13.12 194.05B

About NAVA.OL

Company Profile

NAVA logo image Navamedic ASA engages in the delivery and marketing of pharmaceutical products to patients, hospitals, and pharmacies. The company is headquartered in Oslo, Oslo and currently employs 45 full-time employees. The company went IPO on 2006-03-31. The company is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The firm has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The firm has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.

Company Info

NAVAMEDIC

Henrik Ibsens gate 100

Oslo OSLO NO

Employees: 45

NAVA Company Website

NAVA Investor Relations

Phone: 4767112540

NAVAMEDIC / NAVA.OL FAQ

What is the stock price of NAVAMEDIC today?

The current stock price of NAVA.OL is 26.3 NOK. The price increased by 1.15% in the last trading session.


What is the ticker symbol for NAVAMEDIC stock?

The exchange symbol of NAVAMEDIC is NAVA and it is listed on the Euronext Oslo exchange.


On which exchange is NAVA.OL stock listed?

NAVA.OL stock is listed on the Euronext Oslo exchange.


What is the price forecast or stock price prediction for NAVAMEDIC stock?

7 analysts have analysed NAVA.OL and the average price target is 36.11 NOK. This implies a price increase of 37.3% is expected in the next year compared to the current price of 26.3. Check the NAVAMEDIC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is NAVAMEDIC worth?

NAVAMEDIC (NAVA.OL) has a market capitalization of 464.46M NOK. This makes NAVA.OL a Small Cap stock.


How many employees does NAVAMEDIC have?

NAVAMEDIC (NAVA.OL) currently has 45 employees.


What are the support and resistance levels for NAVAMEDIC (NAVA.OL) stock?

NAVAMEDIC (NAVA.OL) has a support level at 22.87. Check the full technical report for a detailed analysis of NAVA.OL support and resistance levels.


Is NAVAMEDIC (NAVA.OL) expected to grow?

The Revenue of NAVAMEDIC (NAVA.OL) is expected to grow by 9.98% in the next year. Check the estimates tab for more information on the NAVA.OL EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy NAVAMEDIC (NAVA.OL) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does NAVAMEDIC (NAVA.OL) stock pay dividends?

NAVA.OL does not pay a dividend.


What is the Price/Earnings (PE) ratio of NAVAMEDIC (NAVA.OL)?

NAVAMEDIC (NAVA.OL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.71).


NAVA.OL Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to NAVA.OL. When comparing the yearly performance of all stocks, NAVA.OL is a bad performer in the overall market: 66.5% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

NAVA.OL Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to NAVA.OL. The financial health of NAVA.OL is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NAVA.OL Financial Highlights

Over the last trailing twelve months NAVA.OL reported a non-GAAP Earnings per Share(EPS) of -0.71. The EPS decreased by -5.58% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -1.17%
ROE -2.53%
Debt/Equity 0.37
Chartmill High Growth Momentum
EPS Q2Q%-362.72%
Sales Q2Q%9.23%
EPS 1Y (TTM)-5.58%
Revenue 1Y (TTM)6.15%

NAVA.OL Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to NAVA.OL. The Buy consensus is the average rating of analysts ratings from 7 analysts.

For the next year, analysts expect an EPS growth of -43.8% and a revenue growth 9.98% for NAVA.OL


Ownership
Inst Owners32.09%
Ins Owners16.59%
Short Float %N/A
Short RatioN/A
Analysts
Analysts82.86
Price Target36.11 (37.3%)
EPS Next Y-43.8%
Revenue Next Year9.98%